SWAN: Blitzscaling the early detection of skin cancer
Swan is a breakthrough solution to the enduring problem of detecting skin cancer early.
For the first time, Swan enables *full-body* scanning at *dermoscopic* resolution and in less than *3* minutes to the benefit of *all* stakeh...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto SWAN
Duración del proyecto: 24 meses
Fecha Inicio: 2022-06-09
Fecha Fin: 2024-06-30
Líder del proyecto
SQUAREMIND
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Swan is a breakthrough solution to the enduring problem of detecting skin cancer early.
For the first time, Swan enables *full-body* scanning at *dermoscopic* resolution and in less than *3* minutes to the benefit of *all* stakeholders: patients, physicians, hospitals and payers.
The solution captures key data that dermatologists acutely need for early diagnosis and brings breakthrough AI triage assistance to flag concerning lesions. Significant medical time is saved in the process and for patients, the impact is faster access to treatment when needed, fewer unnecessary biopsies and peace of mind.
The solution combines hardware and software and is at the crossroads of cutting-edge, patented technologies in real-time 3D human avatar generation, advanced robotic control, image processing and AI classification of lesions.
Our ambition is to make best-in-class skin cancer screening accessible to everyone, everywhere and finally help dermatology make a quantum leap forward.